SCHEMBL717007

SCHEMBL717007

CC(C)OP(=O)(OC(C)C)[C@@H](Cc1ccc(F)cc1)c1sc2ccccc2c1Br

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.72
PTGS2 P35354 3/20 0.42
PTPN1 P18031 1/20 0.35
CYP2D6 P10635 1/20 0.34
CHRM1 P11229 1/20 0.34
HTR2A P28223 1/20 0.34
HRH1 P35367 1/20 0.34
MAPT P10636 1/20 0.33
CASP3 P42574 2/20 0.33
CASP7 P55210 1/20 0.33
TRPA1 O75762 1/20 0.33
THRB P10828 1/20 0.32
HMGCR P04035 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL718483 1.00 TRPM8 (0.72) TRPM8PTGS2PTPN1CYP2D6CHRM1
SCHEMBL718644 0.88 TRPM8 (0.80) TRPM8PTGS2HMGCRMEN1KMT2A
SCHEMBL718493 0.88 TRPM8 (0.80) TRPM8PTGS2HMGCRMEN1KMT2A
SCHEMBL717742 0.88 TRPM8 (0.80) TRPM8PTGS2HMGCRMEN1KMT2A
SCHEMBL722134 0.87 TRPM8 (0.56) TRPM8PTGS2PTPN1CYP2D6CHRM1
SCHEMBL717270 0.86 TRPM8 (0.69) TRPM8PTGS2HMGCR
SCHEMBL716625 0.86 TRPM8 (0.69) TRPM8PTGS2HMGCR
SCHEMBL718926 0.84 TRPM8 (1.00) TRPM8PTGS2HMGCR
SCHEMBL716815 0.84 TRPM8 (1.00) TRPM8PTGS2HMGCR
SCHEMBL717481 0.84 TRPM8 (1.00) TRPM8PTGS2HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090639-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA N.V. (BE) 2015-07-28 US disclosed
US-20140100194-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA, NV (BE) 2014-04-10 US disclosed
US-8629281-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA, NV (BE) 2014-01-14 US disclosed
US-8558011-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA, NV (BE) 2013-10-15 US disclosed
EP-2029614-B1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2013-01-23 EP disclosed
US-20120184510-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS COLBURN RAYMOND W (US) 2012-07-19 US disclosed
US-20120053347-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2012-03-01 US disclosed
US-7897781-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA NV (BE) 2011-03-01 US disclosed
US-20080287398-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-11-20 US disclosed
US-20080027029-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027029-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885PTPN1 3267/4885
US-20120184510-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885PTPN1 3267/4885
US-20120053347-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885PTPN1 3267/4885
US-20080287398-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885PTPN1 3267/4885
US-20140100194-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885PTPN1 3267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.